跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
IRINOTECAN TARBIS 20 MG/ML CONCENTRADO PARA SOLUCION PARA PERFUSION EFG - CIMA-AEMPS Drug Approval Details
Approvals
/
CIMA-AEMPS
/
IRINOTECAN TARBIS 20 MG/ML CONCENTRADO PARA SOLUCION PARA PERFUSION EFG
Approved
STANDARD
IRINOTECAN TARBIS 20 MG/ML CONCENTRADO PARA SOLUCION PARA PERFUSION EFG
Tarbis Farma S.L.
🇪🇸 Spanish Agency of Medicines and Medical Devices
Approval Date
Mar 1, 2023
Approval ID
95e737fe7398368b
Company
Tarbis Farma S.L.
Type
Standard
Approval Details
Approval Id
95e737fe7398368b
Drug Cima Aemps Name
IRINOTECAN TARBIS 20 MG/ML CONCENTRADO PARA SOLUCION PARA PERFUSION EFG
Register Number
88697
Holder Company Name
Tarbis Farma S.L.
Marketing Company Name
Tarbis Farma S.L.
Authorization Date
2023-03-01
Dosage Form
CONCENTRADO PARA SOLUCIÓN PARA PERFUSIÓN
Dose
20 mg/ml
Route Of Administration
VÍA INTRAVENOSA
Prescription Type
Uso Hospitalario
Commercialized
Yes
Company Name
Tarbis Farma S.L.
Active Ingredients
IRINOTECAN HIDROCLORURO TRIHIDRATO
20 mg/ml
Approved
Quick Info
Agency
CIMA-AEMPS
Country
🇪🇸
Approval Date
Mar 1, 2023
Approval ID
95e737fe7398368b
Type
Standard
Back to CIMA-AEMPS Approvals